BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5037477)

  • 1. [Pharmacologic control of uterine relaxation in pregnancy with orciprenaline].
    Lindmark G; Melander S
    Lakartidningen; 1972 May; 69(21):2555-61. PubMed ID: 5037477
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical use of orciprenaline as an inhibitor of uterine contractility].
    Soto Yances A
    Rev Colomb Obstet Ginecol; 1970; 21(3):219-31. PubMed ID: 5505816
    [No Abstract]   [Full Text] [Related]  

  • 3. [Practical use of orciprenaline in obstetric emergencies].
    Guzmán Sánchez A; Torres Farías E; Ramírez Esparza C
    Ginecol Obstet Mex; 1973 Jul; 34(201):57-65. PubMed ID: 4727875
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of orciprenaline in labor].
    Resta P; Ambrosini A; Polacco V; Tambuscio B
    Minerva Ginecol; 1976 Jun; 28(6):479-85. PubMed ID: 1018829
    [No Abstract]   [Full Text] [Related]  

  • 5. [Alupent in the treatment of treatened premature labor].
    Barbanti A; De Guglielmi F; Cepollini GB
    Minerva Ginecol; 1972 Nov; 24(11):596-600. PubMed ID: 4671721
    [No Abstract]   [Full Text] [Related]  

  • 6. [Is the "temporary correction of fetal hypoxia during labor using Alupent" a reliable method? Comments on the papers in issue 9, volume 38, of Cs.gynekologie].
    Koleta F
    Cesk Gynekol; 1974 May; 39(4):272-3. PubMed ID: 4844889
    [No Abstract]   [Full Text] [Related]  

  • 7. [Orciprenaline (Alupent) for pharmacological relaxation of the uterus during labor].
    Melander S
    Nord Med; 1971 Aug; 86(33):985. PubMed ID: 5094859
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of intra-partum fetal distress. I. Use of beta-mimetic drugs. Orciprenaline].
    Vargas García C; Lowenberg E
    Ginecol Obstet Mex; 1980 Oct; 48(288):231-45. PubMed ID: 7215898
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of premature birth by uterus-inhibiting drugs].
    Lowenberg E; Vargas García C; Rodríguez C
    Ginecol Obstet Mex; 1981 Jun; 49(296):377-91. PubMed ID: 6124485
    [No Abstract]   [Full Text] [Related]  

  • 10. [Action of orciprenaline as an inhibitor of uterine contractions in threatened premature labor. Secondary effects on the maternal cardiovascular system and on the fetal heart rhythm. Clinical contribution].
    Scarpa F; Vucusa C
    Minerva Ginecol; 1976 Jan; 28(1):69-86. PubMed ID: 1256708
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical pharmacology in obstetrics: regulation of the uterus].
    Mosler KH; Linka F
    Med Klin; 1975 May; 70(18):798-805. PubMed ID: 238096
    [No Abstract]   [Full Text] [Related]  

  • 12. [Action of orciprenaline on the contractility of the pregnant uterus and on the fetal cardiac rhythm].
    Pontonnier G; Tournier C; Dat S; Delmas H; Favarel E
    Gynecol Obstet (Paris); 1971; 70(2):157-63. PubMed ID: 5563843
    [No Abstract]   [Full Text] [Related]  

  • 13. [Inhibition of the contractility of the uterus in threatened premature labor using orciprenaline (Alupent). Preliminary report].
    Cobo E; Kafury S
    Rev Colomb Obstet Ginecol; 1970; 21(2):111-7. PubMed ID: 5450670
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tokolysis using Berotec aerosol].
    Kovács L; Herczeg J
    Zentralbl Gynakol; 1978; 100(2):106-9. PubMed ID: 645281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of Salbutamol in obstetrics].
    Dellenbach P; Vors J
    Therapeutique; 1972 Dec; 48(10):671-5. PubMed ID: 4145202
    [No Abstract]   [Full Text] [Related]  

  • 16. [Association of orciprenaline with progestative agents in the treatment of threatened premature labor].
    Pisani G; Sambuco E
    Ann Ostet Ginecol Med Perinat; 1972 Jul; 93(7):506-13. PubMed ID: 4650329
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical studies with a new tocolytic agent (Th 1165 a). Contribution to the management of threatening premature labor].
    Schmidt J; Hirdes G
    Zentralbl Gynakol; 1973 Mar; 95(11):361-9. PubMed ID: 4716652
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevention of premature labor by tocolysis].
    Kölblová V
    Cesk Gynekol; 1977 May; 42(4):302-3. PubMed ID: 862067
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of early threatened abortion (6th-16th week of pregnancy) using a new tocolytic agent (Th 1165a)].
    Bärmig H; Krzoska C
    Zentralbl Gynakol; 1974 Jan; 96(2):55-8. PubMed ID: 4606038
    [No Abstract]   [Full Text] [Related]  

  • 20. [The treatment of late abortion and of threatened premature birth with Th 1165 a combined with Isoptin (author's transl)].
    Weidinger H; Wiest W
    Z Geburtshilfe Perinatol; 1973 Aug; 177(4):233-7. PubMed ID: 4149060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.